Loading...
XNAS
CMPS
Market cap371mUSD
Jul 31, Last price  
4.35USD
1D
-6.76%
1Q
-2.44%
IPO
-86.13%
Name

Compass Pathways PLC

Chart & Performance

D1W1MN
No data to show
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
25.44%
Rev. gr., 5y
%
Revenues
0k
Net income
-155m
L+30.94%
-13,219,000-19,612,000-60,334,000-71,742,000-91,505,000-118,464,000-155,122,000
CFO
-119m
L+22.40%
-9,801,000-17,813,000-41,380,000-67,745,000-105,451,000-97,376,000-119,186,000

Profile

COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.
IPO date
Sep 18, 2020
Employees
181
Domiciled in
GB
Incorporated in
GB

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
178,205
137,162
110,733
Unusual Expense (Income)
NOPBT
(178,205)
(137,162)
(110,733)
NOPBT Margin
Operating Taxes
(1,594)
780
408
Tax Rate
NOPAT
(176,611)
(137,942)
(111,141)
Net income
(155,122)
30.94%
(118,464)
29.46%
(91,505)
27.55%
Dividends
Dividend yield
Proceeds from repurchase of equity
26,219
144,935
440
BB yield
-10.28%
-32.46%
-0.13%
Debt
Debt current
7,238
4,822
1,510
Long-term debt
2,634
34,932
2,346
Deferred revenue
Other long-term liabilities
24,349
Net debt
(155,209)
(180,913)
(139,819)
Cash flow
Cash from operating activities
(119,186)
(97,376)
(105,451)
CAPEX
(66)
(596)
Cash from investing activities
(64)
(596)
Cash from financing activities
63,824
173,830
1,040
FCF
(156,991)
(132,018)
(134,844)
Balance
Cash
165,081
220,198
143,206
Long term investments
469
469
Excess cash
165,081
220,667
143,675
Stockholders' equity
(550,224)
(395,901)
(277,573)
Invested Capital
737,112
657,106
460,614
ROIC
ROCE
EV
Common stock shares outstanding
67,483
51,028
42,436
Price
3.78
-56.80%
8.75
8.97%
8.03
-63.67%
Market cap
255,085
-42.87%
446,495
31.03%
340,763
-61.45%
EV
99,876
265,582
200,944
EBITDA
(177,972)
(136,920)
(110,403)
EV/EBITDA
Interest
4,479
2,213
6,033
Interest/NOPBT